Learn More
Medchemexpress LLC 2-chloro-4-[(3S)-8-[4-[4-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-5,7-dihydropyrrolo... | 2632305-36-1 | 99.4% | 788.33 | C44H46ClN7O5 | 10 MG

Supplier: Medchemexpress LLC HY15611110MG
ARD-1676 is an orally active androgen receptor (AR) proteolysis-targeting chimera (PROTAC) that links an AR ligand to a cereblon ligand to induce targeted degradation of AR. It shows potent AR-degrading activity in vitro and in vivo and suppresses tumor growth in AR-driven VCaP xenograft models.
- Orally active PROTAC degrader targeting the androgen receptor.
- Demonstrated AR degradation in vitro and efficacy in vivo.
- High reported purity (~99.36%).
- Molecular weight approximately 788.33 Da.
- Soluble in DMSO at 100 mg/mL; ultrasonic assistance recommended.
- Storage recommendations: refrigerated; in solvent, -80°C (6 months) or -20°C (1 month), protect from light.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.